Company,Maturity Stage,Discovery Capability,Clinical Impact,Disease Coverage,Biomarker Discovery,Clinical Translation,Real-world Deployment,Evidence Generation,Key Applications
Our Platform,research,4.0,0.5,1.2,6.9,0.5,0.6,0.7,Early-stage research platform with multi-omics integration potential
Our Platform (Year 7 Target),commercial,8.4,10.0,6.0,10.0,10.0,10.0,8.1,Industry-leading federated learning platform with patient-specific biomarker discovery
Tempus Labs,commercial,8.0,9.9,6.0,9.3,9.8,10.0,7.6,Market leader with extensive clinical validation across multiple disease areas
Foundation Medicine,commercial,6.7,10.0,3.2,7.9,10.0,10.0,9.0,FDA-approved genomic profiling with proven clinical utility
Guardant Health,commercial,6.7,9.4,2.5,8.9,10.0,8.5,7.6,FDA-approved liquid biopsy leader with early detection capabilities
Veracyte,commercial,5.2,5.7,2.5,6.9,5.9,5.5,5.0,Specialized genomic testing in specific cancer types
10x Genomics,research,6.5,0.7,3.5,8.2,0.7,0.6,6.8,Research platform with cutting-edge single-cell capabilities
